Brind.

Bayer Aktiengesellschaft and Dexcom were classified within the Large Cap Pharmaceuticals and Medical sectors, with Dexcom showing strong performance.

1 report, 0 independent Updated Jul 3

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Dexcom Incepta Pharmaceuticals

How it developed

Newest first. Tap a step to see who reported it.

Jun 8Amgen's monthly gain underperformed the Medical sector's gain, while operating in the biomedical and genetics industry.Sub-event
Jul 3Dexcom outperformed its industry average while Bayer was classified in the Large Cap Pharma sector.

Keep exploring

The entities involved

Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
- Tandem Mobi utilizes Dexcom G7 technology for monitoring.Mon 09:18
- Oura announces partnerships with Dexcom and Resmed for health feature integration, while noting that regulatory uncertainty affects its product scope.Wed 08:52
Incepta Pharmaceuticals
incepta
- Tilray Brands, Inc.'s stock change lagged the S&P 500 gain on August 28, 2025, while the company holds a Zacks Rank of #3.Sun 03:24
- Precision BioSciences and Incepta Pharmaceuticals were noted as belonging to a specified industry in August 2025.Sat 20:39

Related events

Dexcom and Dentsply Sirona are identified as healthcare companies operating within the same sector.Sep 19

Coverage

Newest first; wire copies grouped

Jul 3Unknown outlet